These compositions could be used to treat twoseemingly unrelated diseases, such as hypertension and the COVID-19disease.81 This is due to the fact thatSARS-CoV-2 enters host cells by utilizing angiotensin-converting enzyme2 (ACE2), an enzyme which is also a target for treatment of hypertension.The described co-amorphous solids of VAL may contribute to establishinga new perspective in the hypertension treatment, in which in additionto taking anti-hypertensive drugs (VAL), patients will also supporttheir anti-viral immune response (NIC). The gene discussed is ACE2; the disease is hypertensive disorder.